Development of monoclonal antibodies to recombinant terrelysin and characterization of expression in Aspergillus terreus

Journal of Medical Microbiology

Volumn 61, Issue 4, 2012, Pages 489-499

  Nayak, Ajay P ^a,b   Green, Brett J ^a   Friend, Sherri ^a   Beezhold, Donald H ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; EPITOPE; FUNGAL EXTRACT; HEMOLYSIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; RECOMBINANT TERRELYSIN; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLUS TERREUS; CONTROLLED STUDY; CYTOPLASM; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS HYPHAE; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MYCELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; ROOM TEMPERATURE;

ANIMALS; ANTIBODIES, MONOCLONAL; ASPERGILLUS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CROSS REACTIONS; EPITOPE MAPPING; EPITOPES; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HEMOLYSIN PROTEINS; HYBRIDOMAS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 84858133939     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.039511-0     Document Type: Article

References (51)

1. Andrew, S. M. & Titus, J. A. (1997). Purification and fragmentation of antibodies. In Current Protocols in Immunology, pp. 2.7.1-2.7.12. Somerset, NJ: Wiley.
2. Baddley, J. W., Pappas, P. G., Smith, A. C. & Moser, S. A. (2003). Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 41, 5525-5529.
3. Balajee, S. A. (2009a). Aspergillus terreus complex. Med Mycol 47 (Suppl. 1), S42-S46.
4. Balajee, S. A., Baddley, J. W., Peterson, S. W., Nickle, D., Varga, J., Boey, A., Lass-Florl, C., Frisvad, J. C., Samson, R. A. & ISHAM Working Group on A. terreus (2009b). Aspergillus alabamensis, a new clinically relevant species in the section Terrei. Eukaryot Cell 8, 713-722.
5. Berne, S., Krizaj, I., Pohleven, F., Turk, T., Macek, P. & Sepcíc, K. (2002). Pleurotus and Agrocybe hemolysins, new proteins hypothetically involved in fungal fruiting. Biochim Biophys Acta 1570, 153-159
6. Berne, S., Pohleven, J., Vidic, I., Rebolj, K., Pohleven, F., Turk, T., Macek, P., Sonnenberg, A. & Sepcic K.(2007).Ostreolysinenhances fruiting initiation in the oyster mushroom (Pleurotus ostreatus). Mycol Res 111, 1431-1436.
7. Berne, S., Lah, L. & Sepcí, K. (2009). Aegerolysins: structure, function, and putative biological role. Protein Sci 18, 694-706.
8. Bhakdi, S., Bayley, H., Valeva, A., Walev, I., Walker, B., Kehoe, M. & Palmer, M. (1996). Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch Microbiol 165, 73-79.
9. Blum, G., Perkhofer, S., Haas, H., Schrettl, M., Wurzner, R., Dierich, M. P. & Lass-Florl, C. (2008). Potential basis for amphotericin B resistance in Aspergillus terreus. Antimicrob Agents Chemother 52, 1553-1555.
10. Chen, C. Y. & Séguin-Swartz, G. (2002). A rapid method for assessing the viability of fungal spores. Can J Plant Pathol 24, 230-232.
11. Chowdhury, H. H., Rebolj, K., Kreft, M., Zorec, R., Macek, P. & Sepcić, K. (2008). Lysophospholipids prevent binding of a cytolytic protein ostreolysin to cholesterol-enriched membrane domains. Toxicon 51, 1345-1356.
12. Chu, L., Bramanti, T. E., Ebersole, J. L. & Holt, S. C. (1991). Hemolytic activity in the periodontopathogen Porphyromonas gingivalis: kinetics of enzyme release and localization. Infect Immun 59, 1932-1940.
13. Crissy, J. T., Lang, H. & Parish, L. C. (1995). Manual of Medical Mycology. Cambridge, MA: Blackwell Sciences.
14. Ebina, K., Yokota, K. & Sakaguchi, O. (1982). Studies on toxin of Aspergillus fumigatus XIV: Relationship between Asp-hemolysin and experimental infection in mice. Jpn J Med Mycol 23, 246-252.
15. Garg, P., Mahesh, S., Bansal, A. K., Gopinathan, U. & Rao, G. N. (2003). Fungal infection of sutureless self-sealing incision for cataract surgery. Ophthalmology 110, 2173-2177.
16. Gravelat, F. N., Doedt, T., Chiang, L. Y., Liu, H., Filler, S. G., Patterson, T. F. & Sheppard, D. C. (2008). In vivo analysis of Aspergillus fumigatus developmental gene expression determined by real-time reverse transcription-PCR. Infect Immun 76, 3632-3639.
17. Hachem, R. Y., Kontoyiannis, D. P., Boktour, M. R., Afif, C., Cooksley, C., Bodey, G. P., Chatzinikolaou, I., Perego, C., Kantarjian, H. M. & Raad, I. (2004). Aspergillus terreus: an emerging amphotericin Bresistant opportunistic mold in patients with hematologic malignancies. Cancer 101, 1594-1600.
18. Han, M. J., Kim, N. J., Lee, S. Y. & Chang, H. N. (2010). Extracellular proteome of Aspergillus terreus grown on different carbon sources. Curr Genet 56, 369-382.
19. Hill, T. W. & Kafer, E. (2001). Improved protocols for Aspergillus minimal medium: trace element and minimal medium stock solutions. Fungal Genet Newsl 48, 20-21.
20. Hilmiǒlu-Polat, S.,Metin, D. Y.,Inci, R., Dereli, T., Kilinç, I. & Tumbay, E. (2005). Non-dermatophytic molds as agents of onychomycosis in Izmir, Turkeya prospective study. Mycopathologia 160, 125-128.
21. Iwen, P. C., Rupp, M. E., Langnas, A. N., Reed, E. C. & Hinrichs, S. H. (1998). Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin Infect Dis 26, 1092-1097.
22. Kohler, G. & Milstein, C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497
23. Kudo, Y., Fukuchi, Y., Kumagai, T., Ebina, K. & Yokota, K. (2001). Oxidized lowdensity lipoprotein-binding specificity of Asphemolysin from Aspergillus fumigatus. Biochim Biophys Acta 1568, 183-188
24. Kudo, Y., Ootani, T., Kumagai, T., Fukuchi, Y., Ebina, K. & Yokota, K. (2002). A novel oxidized low-density lipoprotein-binding protein, Asphemolysin, recognizes lysophosphatidylcholine. Biol Pharm Bull 25, 787-790.
25. Kumagai, T., Nagata, T., Kudo, Y., Fukuchi, Y., Ebina, K. & Yokota, K. (1999). Cytotoxic activity and cytokine gene induction of Asphemolysin to murine macrophages. Nippon Ishinkin Gakkai Zasshi 40, 217-222.
26. Maličev, E., Chowdhury, H. H., Macek, P. & Sepcic, K. (2007). Effect of ostreolysin, an Asp-hemolysin isoform, on human chondrocytes and osteoblasts, and possible role of Asphemolysin in pathogenesis. Med Mycol 45, 123-130.
27. Medina, M. L., Haynes, P. A., Breci, L. & Francisco, W. A. (2005). Analysis of secreted proteins from Aspergillus flavus. Proteomics 5, 3153-3161.
28. Natesan, S., Abraham, G., Mathew, M., Lalitha, M. K. & Srinivasan, C. N. (2007). Secondary sternal Aspergillus osteomyelitis in a diabetic hemodialysis patient with previous allograft rejection. Hemodial Int 11, 403-405.
29. Nayak, A. P., Blachere, F. M., Hettick, J. M., Lukomski, S., Schmechel, D. & Beezhold, D. H. (2011a). Characterization of recombinant terrelysin, a hemolysin of Aspergillus terreus. Mycopathologia 171, 23-34.
30. Nayak, A. P., Green, B. J., Janotka, E., Hettick, J. M., Friend, S., Vesper, S. J., Schmechel, D. & Beezhold, D. H. (2011b). Monoclonal antibodies to hyphal exoantigens derived from the opportunistic pathogen Aspergillus terreus. Clin Vaccine Immunol 18, 1568-1576
31. Nickel, W. (2010). Pathways of unconventional protein secretion. Curr Opin Biotechnol 21, 621-626.
32. Osmani, S. A., Engle, D. B., Doonan, J. H. & Morris, N. R. (1988). Spindle formation and chromatin condensation in cells blocked at interphase by mutation of a negative cell cycle control gene. Cell 52, 241-251.
33. Perfect, J. R., Cox, G. M., Lee, J. Y., Kauffman, C. A., de Repentigny, L., Chapman, S. W., Morrison, V. A., Pappas, P., Hiemenz, J. W. & other authors (2001). The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 33, 1824-1833.
34. Pore, R. S. & Larsh, H. W. (1967). Aleuriospore formation in four related Aspergillus species. Mycologia 59, 318-325.
35. Rao, J., DiGiandomenico, A., Unger, J., Bao, Y., Polanowska-Grabowska, R. K. & Goldberg, J. B. (2008). A novel oxidized lowdensity lipoprotein-binding protein from Pseudomonas aeruginosa. Microbiology 154, 654-665.
36. Rebolj, K., Ulrih, N. P., Macek, P. & Sepcí, K. (2006). Steroid structural requirements for interaction of ostreolysin, a lipid-raft binding cytolysin, with lipid monolayers and bilayers. Biochim Biophys Acta 1758, 1662-1670.
37. Rebolj, K., Batista, U., Sepcić,K.,Cestnik,V.,Macek,P.& Frangez,R. (2007). Ostreolysin affects rat aorta ring tension and endothelial cell viability in vitro. Toxicon 49, 1211-1213.
38. Rubartelli, A. & Sitia, R. (1997). Secretion of mammalian proteins that lack a signal sequence. In Unusual Secretory Pathways: from Bacteria to Man, pp. 87-104 Edited by K. Kuchler & other authors. Austin, TX: R. G. Landes.
39. Rutqvist, L. (1965). Studies on Aspergillus fumigatus; toxin production by different strains and serological comparison of the strains. Acta Vet Scand 6, 224-233.
40. Schmechel, D., Simpson, J. P., Beezhold, D. H. & Lewis, D. M. (2006). The development of species-specific immunodiagnostics for Stachybotrys chartarum: the role of cross-reactivity. J Immunol Methods 309, 150-159.
41. Seeger, W., Obernitz, R., Thomas, M., Walmrath, D., Suttorn, N., Holland, I. B., Grimminger, F., Eberspacher, B., Hugo, F. & Bhakdi, S. (1991). Lung vascular injury after administration of viable hemolysinforming Escherichia coli in isolated rabbit lungs. Am Rev Respir Dis 143, 797-805.
42. Segal, B. H., DeCarlo, E. S., Kwon-Chung, K. J., Malech, H. L., Gallin, J. I. & Holland, S. M. (1998). Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) 77, 345-354.
43. Sukroongreung, S. & Thakerngpol, K. (1985). Abnormal form of Aspergillus terreus isolated from mycotic abscesses. Mycopathologia 91, 47-52.
44. Tiwari, S., Singh, S. M. & Jain, S. (1995). Chronic bilateral suppurative otitis media caused by Aspergillus terreus. Mycoses 38, 297-300.
45. Van Emon, J. M., Reed, A. W., Yike, I. & Vesper, S. J. (2003). ELISA measurement of stachylysin in serum to quantify human exposures to the indoor mold Stachybotrys chartarum. J Occup Environ Med 45, 582-591.
46. Verghese, S., Palani, R., Thirunavakarasu, N., Chellamma, T. & Pathipata, P. (2008). Peritonitis due to Aspergillus terreus in a patient undergoing continuous ambulatory peritoneal dialysis. Mycoses 51, 174-176.
47. Vesper, S. J. & Vesper, M. J. (2004). Possible role of fungal hemolysins in sick building syndrome. Adv Appl Microbiol 55, 191-213.
48. Wadhwani, K. & Srivastava, A. K. (1984). Fungi from otitis media of agricultural field workers. Mycopathologia 88, 155-159.
49. Wartenberg, D., Lapp, K., Jacobsen, I. D., Dahse, H. M., Kniemeyer, O., Heinekamp, T. & Brakhage, A. A. (2011). Secretome analysis of Aspergillus fumigatus reveals Asp-hemolysin as a major secreted protein. Int J Med Microbiol 301, 602-611.
50. Xiang, X., Roghi, C. & Morris, N. R. (1995). Characterization and localization of the cytoplasmic dynein heavy chain in Aspergillus nidulans. Proc Natl Acad Sci U S A 92, 9890-9894.
51. Žužek, M. C., Macek, P., Sepcić, K., Cestnik, V. & Frangez, R.(2006). Toxic and lethal effects of ostreolysin, a cytolytic protein from edible oyster mushroom (Pleurotus ostreatus), in rodents. Toxicon 48, 264-271.